Russian researchers have developed a candidate vaccine to protect against the deadly Ebola virus which will soon undergo human clinical trials in Africa.
China on Thursday said it has developed a vaccine to combat the spread of deadly Ebola virus that has killed more than 7,000 people in three West African countries, and the test of the drug on huma
This brief summarizes FEWS NET’s most forward-looking analysis of projected emergency food assistance needs in FEWS NET coverage countries. The projected size of each country’s acutely food insecure population is compared to last year and the recent five-year average.
PERCHED on a hill in Geneva above the city’s cluster of international agencies, the modernist headquarters of the World Health Organisation (WHO, pictured above) seems a manifestation of the organi
Monrovia — The World Bank has signed an additional US$115M financing grant agreement of the Ebola Emergency Response Project with the Government of Liberia (GoL).
Ebolaviruses cause a severe and often fatal haemorrhagic fever in humans, with some species such as Ebola virus having case fatality rates approaching 90%. Currently, the worst Ebola virus outbreak since the disease was discovered is occurring in West Africa. Although thought to be a zoonotic infection, a concern is that with increasing numbers of humans being infected, Ebola virus variants could be selected which are better adapted for human-to-human transmission.
Beyond its terrible toll in human lives and suffering, the Ebola epidemic has inflicted a measurable economic impact on West Africa in terms of forgone output, higher fiscal deficits, rising prices, lower real household incomes, and greater poverty.